Clinical Trials Directory

Trials / Completed

CompletedNCT02320344

Partnerships to Improve Lifestyle Interventions (PILI) 'Ohana Dissemination Project Partners in Care

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
47 (actual)
Sponsor
University of Hawaii · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The 3-month face-to-face Partners in Care intervention will be community-based and community-led by trained community peer educators from these four partnering community organizations. The intervention involves 12 weekly, group lessons with each lesson lasting about 1 and 1/2 hours. Individuals with a hemoglobin A1c (HbA1c; average blood sugar levels) greater than or equal to 7% will be recruited for the study because they represent the most at-risk for diabetes-related complications. Over a 3-year accrual period, the community partners will recruit and enroll 150 eligible NHs and PPs, as well as deliver and evaluate the intervention in their respective community settings. The primary outcomes of our study are hemoglobin A1c and self-reported diabetes specific quality of life. Secondary outcomes are cholesterol levels (including HDL, LDL, total cholesterol, and triglycerides), blood pressure, body mass index, and psychosocial adaptation.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPartners in CareThe diabetes self-management intervention is titled, "Partners in Care," emphasizing that there are many individuals and groups that one can call upon to assist with managing one's diabetes. The content includes practical behavioral strategies to improve diabetes self-management practices. The 12 week curriculum provides a basic overview of diabetes and self-management activities, standards of care recommended by the American Diabetes Association, strategies to improve patient-provider communication, support needed for diabetes self-management, information about diabetes medications, and ways to avoid diabetes-related complications.

Timeline

Start date
2013-07-01
Primary completion
2017-12-01
Completion
2017-12-01
First posted
2014-12-19
Last updated
2018-05-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02320344. Inclusion in this directory is not an endorsement.